Reference Susceptibility Testing and Genomic Surveillance ofClostridioides difficile, United States, 2012–17
Author(s) -
Amy S. Gargis,
Maria Karlsson,
Ashley Paulick,
Karen Anderson,
Michelle Adamczyk,
Nicholas Vlachos,
Alyssa G. Kent,
Gillian McAllister,
Susannah L. McKay,
Alison Laufer Halpin,
Valérie Albrecht,
Davina Campbell,
Lauren Korhonen,
Christopher A. Elkins,
J. Kamile Rasheed,
Alice Guh,
L. Clifford McDonald,
Joseph D. Lutgring,
Ghinwa Dumyati,
Scott K. Fridkin,
Dale N. Gerding,
Stacy Holzbauer,
Helen Johnston,
Danyel Olson,
Rebecca Perlmutter,
Erin C. Phipps,
Rebecca Pierce,
Christopher Wilson,
Lisa G. Winston
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac817
Subject(s) - vancomycin , clindamycin , moxifloxacin , microbiology and biotechnology , meropenem , metronidazole , fidaxomicin , biology , clostridium difficile , antibiotic resistance , antibiotics , minimum inhibitory concentration , bacteria , genetics , staphylococcus aureus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom